scorecardresearch
Wednesday, July 23, 2025
TopicPfizer

Topic: Pfizer

Pfizer vaccine could offer protection against new Covid variant, shows study

The study showed the vaccine is likely to generate a protective immune response to new coronavirus variants carrying the so-called N501Y mutation in the virus’s spike protein.

WHO’s vaccine advisory body recommends administering both doses of Pfizer within 21-28 days

WHO's Strategic Advisory Group of Experts on Immunisation (SAGE), however, said countries can space out doses depending on vaccine supply constraints and epidemiological settings.

Everything we know about Covishield, one of 2 Covid vaccines likely to get nod for use in India

Covishield is Serum Institute of India’s version of the Oxford-AstraZeneca vaccine that had been in the works for several months.

Pfizer backs two-dose Covid vaccine schedule after UK spaces out shots

People should get their shots on the recommended schedule, Pfizer said, warning 'there is no data to demonstrate that protection after the first dose is sustained after 21 days.'

You thought coronavirus is our newsmaker of 2020? No, it’s science-made mRNA, its nemesis

The mRNA technology never won approval before the Covid pandemic in any drug or vaccine. But Hungarian biochemist Katalin Karikó never gave up on her research either.

Over 1 million people in US have received Covid vaccine shots

Shots are rolling out from Pfizer and Moderna, focused at first on healthcare workers around the country who have been battling the virus on the front lines in hospitals.

Dubai to offer free Pfizer-BioNTech Covid vaccine shots from Wednesday

Dubai locked down the city for about a month earlier this year to halt the spread of the virus. The UAE diagnosed over 195,000 people with Covid since the start of the outbreak.

Singapore approves Pfizer Covid vaccine, expects first shots by December-end

Singapore PM Lee Hsien Loong said first priority will be given to those who are at greatest risk: healthcare workers and front-line personnel, as well as the elderly and vulnerable.

Pfizer could give Covid vaccine shots to trial participants who received placebo

Pending required approvals, Pfizer & BioNTech plan to provide option for clinical trial participants who received the placebo to get Covid vaccine, the company said in a statement.

Pfizer shot gets FDA advisers’ nod as agency decision on emergency authorisation nears

Committee of advisers voted 17 to 4, with one abstention, that the benefits of the vaccine from Pfizer Inc. and BioNTech SE outweigh the risks for use in people ages 16 and older.

On Camera

Modi govt has learned from past FTAs. Its priority now is building a manufacturing powerhouse

Past FTAs failed to yield much benefit because they exposed domestic industries to global competition without strengthening the manufacturing ecosystem.

India-US set to ink mini trade deal soon, reach understanding on agricultural & dairy products

Mini deal will likely see no cut in 10% baseline tariff on Indian exports announced by Trump on 2 April, it is learnt, but additional 26% tariffs are set to be reduced.

Indian firm sets up titanium, superalloy plants to meet global need. Safran, Dassault, BAE line up

PTC Industries is investing Rs 1,000 cr in 4 manufacturing plants in UP, has already started supplying titanium parts to BAE Systems for its M-777 howitzers that India also uses.

Strategic partner one day, tactical nightmare the next: India’s learning Trumplomacy the hard way

Public, loud, upfront, filled with impropriety and high praise sometimes laced with insults. This is what we call Trumplomacy. But the larger objective is the same: American supremacy.